Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
Maternal serum alphafetoprotein (MSAFP) screening has been set up in Asturias, in the north of Spain, in 1987 in order to make possible the prenatal diagnosis of neural tube defects (NTD) to overall pregnancy population. This large study shows the high sensitivity and specificity of MSAFP screening when it is done with absolute control of all variables such as gestational age, pregnant woman's weight, diabetes, etc. On the other hand, this study also shows a poor sensitivity second level ultrasound for the early diagnosis of NTD in the presence of spina bifidas with no bulge. We have also observed that the incidence of NTD in Asturias remained constant in the last six years, around 1.5-1.6 per 1000 pregnancies. However, due to MSAFP screening, there has been a decline in the prevalence of children born with these defects. We conclude that MSAFP screening is the best tool to identify and reduce NTD in our Region (Spain).
Candenas
M
M
Department of Clinical Analysis, Hospital San Agustín, Avilés-Asturias, Spain.
Villa
R
R
Fernandez Collar
R
R
Moina
M J
MJ
Pintado
S
S
Garcia Saez
F
F
Alvarez
F V
FV
D005260:Female; D005315:Fetal Diseases / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D015994:Incidence; D009436:Neural Tube Defects / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D011237:Predictive Value of Tests; D011247:Pregnancy; D011296:Prenatal Diagnosis; D015995:Prevalence; D016730:Program Development; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D000509:alpha-Fetoproteins / Q000032:analysis*
D000509:alpha-Fetoproteins